Header Logo

Connection

PREMAL LULLA to Immunotherapy

Back to Details
This is a "connection" page, showing publications PREMAL LULLA has written about Immunotherapy.
PREMAL LULLA
Connection Strength
0.488
Immunotherapy
  1. Incipient clonal hematopoiesis is accelerated following CD30.CAR-T therapy. Cytotherapy. 2024 03; 26(3):261-265.
    View in: PubMed
    Score: 0.153
  2. Emerging Challenges to Cellular Therapy of Cancer. Cancer J. 2023 Jan-Feb 01; 29(1):20-27.
    View in: PubMed
    Score: 0.143
  3. Myelodysplastic syndrome and immunotherapy novel to next in-line treatments. Hum Vaccin Immunother. 2021 08 03; 17(8):2602-2616.
    View in: PubMed
    Score: 0.128
  4. Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood. 2024 04 25; 143(17):1726-1737.
    View in: PubMed
    Score: 0.039
  5. Characterizing the Cellular Immune Response to Parainfluenza Virus 3. J Infect Dis. 2017 07 15; 216(2):153-161.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.